- NSE
Cipla Limited
Healthcare CIPLA
1328.00INR
16.40
(
1.25%)
Last update at
Day Range
52 Week Range
Fundamentals
- Previous Close 1311.60
- Market Cap 1183505.97M
- Volume1,185,676
- P/E Ratio 21.74
- EBITDA 70936.40M
- Revenue TTM 279658.20M
- Revenue Per Share TTM 346.26
- Gross Profit TTM 185980.60M
- Diluted EPS TTM 67.38
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Past Performance
| Status | Stocks | Entry Price | Entry Date | Exit Date | Duration | Duration Type | Sector | *Return(%) |
|---|---|---|---|---|---|---|---|---|
| CLOSED | CIPLA | ₹ 1515.70 | 4/11/25 | 4/11/25 | Same Day | Short Term | Healthcare | -0.79% |
| CLOSED | CIPLA | ₹ 1499.85 | 18/03/25 | 18/03/25 | Same Day | Short Term | Healthcare | 0.72% |
| CLOSED | CIPLA | ₹ 1452.00 | 11/03/25 | 11/03/25 | Same Day | Short Term | Healthcare | 0.69% |
| CLOSED | CIPLA | ₹ 1457.00 | 14/02/25 | 14/02/25 | Same Day | Short Term | Healthcare | 0.24% |
Financials
Income Statement
Balance Sheet
Change in Cash
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Income before tax | 67989.60M | 57003.10M | 40383.50M | 34932.70M | 32900.60M |
| Net income | 52725.20M | 41215.50M | 28019.10M | 25167.50M | 24048.70M |
| Total Revenue | 272674.40M | 255367.10M | 224731.80M | 216327.60M | 189968.30M |
| Gross Profit | 180921.40M | 164927.60M | 142209.00M | 124030.40M | 109764.50M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 373870.40M | 327178.20M | 294632.80M | 271011.20M | 251518.90M |
| Intangible assets | 17161.20M | 16010.00M | 15301.40M | 17028.60M | 18282.60M |
| Other current assets | 15228.40M | 16369.30M | 8489.90M | 88.00M | 93.10M |
| Deferred long term liab | - | - | - | - | - |
| Non current assets other | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Change in Cash | 303.10M | -489.90M | -967.80M | -1323.20M | 509.10M |
| Operating Cash | 50049.80M | 41339.10M | 32376.50M | 33259.00M | 37552.00M |
| Free Cash Flow | 38428.20M | 27846.10M | 20547.60M | 26247.50M | 29362.80M |
Peer Comparison
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
| Company | Change | Price | Market Cap (M) | P/E Ratio |
|---|---|---|---|---|
| CIPLA Cipla Limited |
16.40 1.25% | 1328.00 | 1183505.97 | 21.74 |
| SUNPHARMA Sun Pharmaceutical Industries Limited |
75.40 4.63% | 1703.30 | 4224508.76 | 40.32 |
| DIVISLAB Divi's Laboratories Limited |
336.50 5.65% | 6289.00 | 1752225.28 | 70.47 |
| TORNTPHARM Torrent Pharmaceuticals Limited |
39.90 1.00% | 4027.10 | 1362716.66 | 63.48 |
| DRREDDY Dr. Reddy's Laboratories Limited |
53.70 4.54% | 1236.20 | 1004813.29 | 17.16 |
Profile
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Cipla Limited
Cipla House, Mumbai, India, 400013
- 91 22 2482 6000
- https://www.cipla.com
- Employees : 30,313
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Umang Vohra | MD, Global CEO & Exec. Director | 1971 |
| Ms. Samina Hamied | Exec. Vice-Chairperson | 1976 |
| Dr. Raju Sunil Mistry M.A., Ph.D. | Pres & Global Chief People Officer | 1965 |
| Mr. Pradeep Bhadauria | Pres & Chief Scientific Officer | NA |
| Mr. Ashish Adukia | Global Chief Financial Officer | NA |
| Mr. Dinesh Ramniranjan Jain | Sr. VP & Head of Corp. Fin. | NA |
| Ms. Geena V. Malhotra | Global Chief Technology Officer | NA |
| Mr. Naveen Bansal | Head of Investor Relations | NA |
| Mr. Gautam Rohidekar | Chief Legal Officer | NA |
| Mr. Rajendra Kumar Chopra | Compliance Officer & Company Sec. | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.